Pancreatic cancer treatment with targeted therapies: are we there yet

QR Code

Pancreatic cancer treatment with targeted therapies: are we there yet

Objective: Pancreatic cancer (PaCa) is a disease that is extremely difficult to treat and is associated with a high fatality rate. The majority of patients present to hospitals with metastatic or end-stage cancer, making the ultimate cure impossible. End-stage PaCa has no specific treatment, though...

Full description

Bibliographic Details
Main Authors:	Nwaefulu, O. Ngozi, Sagineedu, S. Rao, Islam, M. Kaisarul, Stanslas, J.
Format:	Article
Published:	Verduci International 2022
Online Access:	http://psasir.upm.edu.my/id/eprint/102436/

Similar Items

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

Are we there Yet
by: Gray, Michael
Published: (2010)

Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)

The impact of cycleanine in cancer research: a computational study
by: Nwaefulu, Ogochukwu Ngozi, et al.
Published: (2022)

Assessing iron overload: Are we there yet?
by: Kruger, P., et al.
Published: (2012)

Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer
by: Islam, Mohammad Kaisarul, et al.
Published: (2021)

The tipping point: are we nearly there yet?
by: Whitworth, Anne
Published: (2017)

Long-term cancer risks in women after treatment with IVF: do we have any answers yet?
by: Stewart, Louise, et al.
Published: (2015)

Mediterranean Diet and Cardiovascular Risk: Are We There Yet?
by: Huxley, Rachel, et al.
Published: (2013)

International Students Friendly Library - Are We There Yet.
by: Mohamad, Radia Banu Jan, et al.
Published: (2012)

More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro
by: Yuan, Han Teh, et al.
Published: (2023)

Embracing the Internet of Things for Language Education: Are We There Yet?
by: Hafizoah, Kassim, et al.
Published: (2019)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
by: Prosser, H., et al.
Published: (2017)

Ethnobotanical study of anticancer plants used in Ugbine, Nigeria and bioactivity-guided isolation of cytotoxic agents from Synclisia scabrida (Miers) ex oliv
by: Ngozi, Nwaefulu Ogochukwu
Published: (2022)

International business education: What we know and what we have yet to develop
by: Klarin, Anton, et al.
Published: (2021)

Hypermutation In Pancreatic Cancer
by: Humphris, J., et al.
Published: (2017)

Reporting assurance for religious compliance in Islamic banks: are we there yet?
by: Sheikh Hassan, Ahmad Fahmi, et al.
Published: (2015)

Keep following SOP, we're not out of the woods yet
by: The Star
Published: (2021)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

'Stay safe as we're not out of the Covid-19 woods yet'
by: Shah, Aliza
Published: (2022)

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)

Preoperative drainage in pancreatic cancer
by: Kennedy, Eugene P, et al.
Published: (2010)

Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)

Mesoporous silica nanoparticles as anticancer drug carriers in pancreatic cancer treatment
by: Chung, Shei Li
Published: (2025)

Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
by: Min-Wen, J., et al.
Published: (2017)

Cancer-associated membrane protein as targeted therapy for bladder cancer
by: Roslan, Adlina, et al.
Published: (2022)

Towards targeted cancer therapy: Aptamer or oncolytic virus?
by: Tan, K., et al.
Published: (2017)

Targeting platelets for the treatment of cancer
by: Elaskalani, Omar, et al.
Published: (2017)

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
by: Abrams, S., et al.
Published: (2018)

We are still not yet out of the woods in W.A.: Western Australia and the international tobacco industry
by: Stafford, Julia, et al.
Published: (2009)

The rock physics basis for 4D seismic monitoring of CO2 fate: Are we there yet?
by: Vanorio, T., et al.
Published: (2010)

Are We Out Of The Woods Yet? An Analysis Of Figurative Expressions Utilized In Taylor Swift’s 1989 Album
by: Nursyaheedah, Muhammad Isa, et al.
Published: (2017)

DNA repair in cancer: emerging targets for personalized therapy
by: Abbotts, Rachel, et al.
Published: (2014)

Cancer stem cell metabolism: A potential target for cancer therapy
by: Deshmukh, A., et al.
Published: (2016)

Investigation of Novel Biomarkers for Pancreatic Cancer
by: Emmanouilidi, Aikaterini
Published: (2019)

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)